INSIGHTS ON DRUG DEVELOPMENT

• Small Molecule Orphan Drugs: Status Quo, Challenges, And Perspectives

  By establishing robust manufacturing processes and scalable production strategies from the outset, developers can help de-risk orphan drug production, improve efficiency, and position their programs for greater long-term success.

• Your Guide To Precise And Robust Separation Methods

  Discover a detailed guide to characterizing GLP-1 receptor agonists that covers advanced LC-MS and SEC-MALS workflows for impurity profiling, stability testing, and aggregate analysis.

• Simplify Your Cell Culture Processes

  Discover bioreactors that combine fast setup, robust design, and scalable performance to streamline cell culture workflows, which help you move from uncertainty to control, no matter your molecule.

• Streamlining Drug Development: From Developability Assessment To High-Concentration Formulation Development

  Explore a strategic approach to accelerating biologics formulation by gaining early insight into molecular properties and optimizing high-concentration conditions with minimal protein input.

• Generate CHO-K1 GFP-Expressing Cells For Cell Line Development Workflow

  11/7/2025

  Discover a high-efficiency workflow for generating GFP-expressing CHO-K1 clones using automated single-cell dispensing to achieve 93% isolation success and stable expression in under five weeks.

• How To Get Started With Organ-On-A-Chip Technology

  4/18/2024

  Explore the advantages of Organ-on-a-Chip technology over 2D cell culture as well as data-driven examples demonstrating the enhanced physiological relevance of Organ-Chips.

• Accelerating Drug Development: Flexible And Fast DNA-To-IND Programs

  7/8/2024

  Gain expert insights on how tailored approaches and innovative technologies enable fast and flexible development workflows, ultimately supporting rapid therapeutic breakthroughs.

• Streamlining Biologics Development: Leveraging Small-Scale Studies For Greater Efficiency

  9/25/2025

  Uncover how a data-driven approach to small-scale studies not only accelerates development timelines but also enhances decision-making and resolves full-scale manufacturing challenges across diverse biologic modalities.

• Digital Transformation Essentials: AI Readiness, What Do You Need To Know?

  6/22/2024

  Unlock the full potential of AI and digital solutions with these practical steps to begin moving your BioPharma organization's goals forward with optimized data usage.